Oral Session 1-8D Malignant Lymphoma: Clinical studies

[OS1-8D-5] Phase Ib study of copanlisib in Japanese patients with relapsed/refractory indolent B-cell lymphoma

Noriko Fukuhara¹, Dai Maruyama², Kiyohiko Hatake³, Hirokazu Nagai⁴, Kenjiro Kamezaki⁵, Saori Kosaka⁶, Kensei Tobinai² (1.Hematology and Rheumatology, Tohoku Univ., Sendai, Japan, 2.Hematol., National Cancer Cent., Tokyo, Japan, 3.Cancer Inst. Hosp., Japanese Found. for Cancer Res., Tokyo, Japan, 4.Hematol., National Hosp. Nagoya Med. Cencer, Nagoya, Japan, 5.Cellular and Molecular Med., Kyushu Univ., Fukuoka, Japan, 6.Bayer Yakuhin, Ltd., Osaka, Japan)